<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Case Study: Objective Pain Quantification | Ian Chan</title>
    <link rel="stylesheet" href="styles.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Lora:wght@400;700&family=Montserrat:wght@400;700&display=swap" rel="stylesheet">
</head>
<body>

    <header class="project-header">
        <div class="wrapper">
            <h1>Investment Thesis: Objective Pain Quantification Device</h1>
            <p>A quantamental approach to generating proprietary alpha from alternative data.</p>
        </div>
    </header>

    <main class="project-content">
        <div class="wrapper">
            <h3>Executive Summary</h3>
            <p>Pain is a subjective, multi-billion dollar problem for the healthcare industry, impacting everything from clinical trial efficacy to treatment protocols. This case study details the development of a predictive model that quantifies pain objectively using physiological data. The process is directly analogous to creating a multi-factor alpha model, demonstrating a core competency in extracting predictive signals from noisy, alternative datasets to create a proprietary analytical edge.</p>

            <h3>The Market Opportunity</h3>
            <p>The current gold standard for pain assessment is the self-reported 1-10 scale, a method plagued by subjectivity and bias. This creates massive inefficiencies in drug development, where inaccurate pain reporting can obscure a therapeutic's true efficacy, leading to failed trials and billions in lost investment. A reliable, objective measure of pain would be a transformative tool for pharmaceutical companies, contract research organizations (CROs), and clinical settings, creating a substantial and untapped market opportunity.</p>

            <h3>Quantitative Analysis & Validation</h3>
            <p>A predictive model was built using Python (Pandas, Scikit-learn) to process and analyze complex physiological data streams, including Galvanic Skin Response (GSR) and Electromyography (EMG). The core of the analysis involved:</p>
            <ul>
                <li><strong>Data Ingestion & Cleaning:</strong> Processing raw sensor data to handle noise and artifacts.</li>
                <li><strong>Feature Engineering:</strong> Identifying and extracting the most predictive features from the time-series data that correlate with nociceptive responses.</li>
                <li><strong>Model Selection:</strong> Training and validating several machine learning models to identify the most robust and accurate algorithm for predicting pain states.</li>
                <li><strong>Validation:</strong> Rigorously testing the model's performance on out-of-sample data to ensure its predictive power and generalizability.</li>
            </ul>
            <p>This entire workflow mirrors the process of a quantitative analyst developing a multi-factor model to forecast asset returns based on disparate data inputs, proving an ability to manage a full "quant" project lifecycle.</p>
            
            <h3>Investment Thesis & Commercial Application</h3>
            <p>The resulting model represents a proprietary analytical asset. For a HealthTech or BioTech investor, this is a "quantamental" tool. It can be used to more accurately assess the clinical trial data of pharmaceutical companies developing analgesics, providing a data-driven edge in due diligence. A company possessing this technology would have a significant competitive advantage, able to offer a "Pain-as-a-Service" platform to CROs, de-risking their clinical trials and commanding premium pricing.</p>

            <a href="index.html#theses" class="back-link">‚Üê Back to Investment Theses</a>
        </div>
    </main>

    <footer class="site-footer">
        <div class="wrapper">
            <p>&copy; 2025 Ian H.Y. Chan. All Rights Reserved.</p>
        </div>
    </footer>

</body>
</html>